23
Participants
Start Date
April 30, 2011
Primary Completion Date
January 31, 2017
Study Completion Date
June 30, 2017
Panobinostat, Cisplatin, Pemetrexed
"Drug: Panobinostat Oral (by mouth) once daily every Monday, Wednesday, and Friday for the first two weeks of each three week cycle (as per dose escalation schedule (dose levels 1 and 2: AUC 5; dose levels 3 and 4: AUC 6). Number of cycles: 6 maximum.~Drug: Cisplatin IV (in the vein) on day 1 of a 21-day cycle Number of cycles: 6 maximum. Drug: Pemetrexed IV (in the vein) on day 1 of a 21-day cycle Other: Correlative studies Biomarker Analysis: blood collected pre-study and Cycles 2-6, Day 1."
Henry Ford Health System, Detroit
University of California Davis Cancer Center, Sacramento
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
University of California, Davis
OTHER